Latest News

Asthma drug can inhibit changes in early stages of diabetic retinopathy

In a study published July 26 online in the journal Diabetes, physician-researchers from University Hospitals Rainbow Babies and Children’s Hospital and Case Western Reserve University School of Medicine found that the asthma medication montelukast (brand name Singulair) can inhibit early changes in diabetic retinopathy, the eye disease which develops due to diabetes, in a mouse model of type 1 diabetes.

Source link

Related posts

Excessive Tea Drinking Have Serious Repercussions


Thoughts on body image during pregnancy could indicate women’s emotional wellbeing


Examining Pennsylvania’s Proposed Ban On Feeding Wildlife


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy